Pune, India, Feb. 03, 2023 (GLOBE NEWSWIRE) — The global Active Pharmaceutical Ingredients Market The size was $159.35 billion in 2020. The market is expected to grow from $174.17 billion in 2021 to $272.44 billion in 2028 at a CAGR of 6.6% over the period 2021-2028. According to our expert analysts, the increasing prevalence of chronic diseases and rising demand for modified medicine coupled with the emergence of novel drug delivery devices are just some of the aspects that are believed to play a crucial role in enhancing the growth of the active pharmaceutical ingredients market over the course of the year play mentioned period.

key industry development

• Amgen confirmed its acquisition of Rodeo Therapeutics, a biopharmaceutical company focused on developing small molecule therapies. The acquisition will allow Amgen to expand its portfolio of anti-inflammatory drugs.
• Wavelength Pharmaceuticals completed the acquisition of a controlling interest in Vanamali Organics Pvt. ltd based in Telangana, India to strengthen its global supply chain.

Request a sample copy of the research report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/active-pharmaceutical-ingredient-api-market-102656

Report scope and segmentation

The central theses

• As the pharmaceutical industry expands daily, several nations have implemented strict regulatory guidelines for the manufacture of pharmaceutical ingredients.
• Demand for multiple vaccines, 40% of demand for generic brands sold in the United States and 25% of demand for all drugs in the UK are all met by the Indian pharmaceutical industry.
• China’s pharmaceutical sector is growing faster than any other after India.
• In 2020, there will be 2.7 million new cancer cases and 1.3 million deaths in the European Region.

driver and…